Ahmed Abdel Hakim, Fatma Gamal Al Saidi, Ihab Gomaa, Abdel Latif Elkholy, Ahmed Abbas
Background: Letrozole is an aromatase inhibitor that decreases the risk of Ovarian Hyperstimulation Syndrome (OHSS) in assisted reproductive technology. We aimed to evaluate the clinical outcomes of high-risk patients undergoing different Intracytoplasmic Sperm Injection (ICSI) protocols, one with letrozole …